2020
On October 14, 2020, in partnership with the Daniels Fund Ethics Initiative Collegiate Programs at the CU Denver Business School and the CU Boulder Leeds School of Business, the Collegiate Program at Colorado Law presented “Carnival’s Compliance Journey,” featuring Peter Anderson, Carnival Corporation’s first-ever Chief Ethics and Compliance Officer. We heard the inside story of the world’s largest cruise line operator from the man tasked with overhauling its ethics and compliance system as the company strives to overcome a long history of environmental crimes. Mr. Anderson discussed Carnival’s voyage from being the company subject to the largest fine in U.S. history for deliberate vessel pollution, to one that now aspires to embody a culture of compliance and adherence to not only legal and statutory requirements, but also to the highest ethical principles. Mr. Anderson also discussed how, in the midst of an already daunting compliance task, he then had to navigate the devastating impacts of the unexpected coronavirus pandemic, just as one of Carnival’s ships surfaced as an early epicenter for the disease.
Mr. Anderson is a former federal prosecutor with over 20 years of experience in corporate compliance. He served with the U.S. Department of Justice Environmental Crimes Division and later, was the head of the White Collar and Compliance Group at Beveridge & Diamond, PC. Mr. Anderson was initially engaged by Carnival to conduct a compliance program assessment, and was later appointed CECO. Immediately prior to his engagement with Carnival, Anderson led the environmental compliance team on the Volkswagen monitorship.
2019
On April 8, 2019, the Daniels Fund Ethics Initiative at Colorado Law welcomed John Carreyrou, two-time Pulitzer Prize-winning investigative reporter at The Wall Street Journal and author of the national best-seller Bad Blood: Secrets and Lies in a Silicon Valley Startup. The lecture, presented in partnership with CU Denver, was entitled “Theranos: A Cautionary Tale of Ethics in Entrepreneurship.” The lecture covered the full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, as chronicled by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from Theranos’ charismatic CEO and threats by her lawyers. Carreyrou’s lecture focused on the ethical implications of the fraud committed by Theranos.
